Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble CoInhibitory and CoStimulatory Immune Checkpoint Molecules

Abstract

Description

Keywords

Citation

WOS

Endorsement

Review

Supplemented By

Referenced By